Identification of antigenic sites on three hepatitis c virus proteins using phage-displayed peptide libraries

Journal of Medical Virology

Volumn 56, Issue 2, 1998, Pages 105-111

  Pereboeva, L A ^a,b   Pereboev, A V ^a,b   Morris, G E ^a  

^a GLYNDWR UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Antigenic determinant; Diagnosis; Epitope; Filamentous bacteriophage; Vaccine

Indexed keywords

BACTERIOPHAGE DNA; EPITOPE; PEPTIDE LIBRARY; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EPITOPE MAPPING; HEPATITIS C VIRUS; IMMUNE RESPONSE; NONHUMAN; PHAGE DISPLAY; PURIFICATION;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; BACTERIOPHAGES; DNA, COMPLEMENTARY; DNA, VIRAL; EPITOPE MAPPING; HEPACIVIRUS; HEPATITIS; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0031706060     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199810)56:2<105::AID-JMV1>3.0.CO;2-C     Document Type: Article

References (24)

1. Barbas SM, Barbas CF (1994): Filamentous phage display. Fibrinolysis 8(Suppl.1):245-252.
2. Bhattacherjee V, Prescott LE, Pike I, Rodrigers B, Bell H, El-Zayadi AR, Kew MC, Conradie J, Lin CK, Marsden H, Saeed AA, Parker D, Yap P-L, Simmonds P (1995): Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. Journal of General Virology 76:1737-1748.
3. Burton DR (1995): Phage display. Immunotechnology 1:87-94.
4. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradly DW, Houghton M (1989): Isolation of cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 244:359-362.
5. Choo QL, Richman KH., Han JH, Berger K, Lee C, Dong C, Callegos C, Coit D, Medina-Selby A, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Hougton, G (1991): Genetic organisation and diversity of the hepatitis C virus. Proceedings of National Academy of Sciences of USA 88:2451-2455.
6. Claeys H, Volckaerts A, Mertens W, Liang Z, Fiten P, Opdenakker G (1995): Localization and reactivity of an immunodominant domain in the NS3 region of the hepatitis C virus. Journal of Medical Virology 45:273-281.
7. Du Plessis DH, Romito M, Jordaan F (1995): Identification of an antigenic peptide specific for bluetongue virus using phage display expression of NS1 sequences. Immunotechnology 1:221-230.
8. Folgori A, Tafi R, Meola A, Felici F, Galfre G, Cortese R, Monaci P, Nicosia A (1994): A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. The EMBO Journal 13:2236-2243.
9. Germashewski V, Murray K (1996): Identification of polyclonal serum specificities with phage-display libraries. Journal of Virological Methods 58:211-232.
10. Goeser T, Muller M, Ye J, Pfaff E, Theilmann, L (1994): Characterization of antigenic determinants in the core antigen of the hepatitis C virus. Virology 205:462-469.
11. Ivanisenko VA, Eroshkin AM (1997): Searching protein sites with functionally important amino acid changes in the sets of natural and mutant proteins. Molecular Biology 31:896-903.
12. Khudyakov YE, Khudyakova NS, Jue DL, Lambert SV, Fang S Fields HA (1995): Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modelled with synthetic peptides. Virology 206:666-672.
13. Kleinman S, Alter H, Busch M, Holland P, Tegtmeier G, Nelles M, Lee S, Page E, Wilber J, Polito A (1992): Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 32:805-813.
14. Mondelli MU, Cerino A, Boender P, Oudshoorn P, Middeldorp J, Fipaldini C, La Monica N, Habets W (1994): Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. Journal of Virology 68:4829-4836.
15. Okamoto H, Tsuda F, Machida A, Munecata E, Akahane Y, Sugai Y, Mashiko K, Mitsui T, Tanaka T, Miyakawa Y, Mayumi M (1992): Antibodies against synthetic oligopeptides deduced from the putative Core gene for the diagnosis of hepatitis C virus infection. Hepatology 15:180-186.
16. Pereboev A, Morris GE (1996): Reiterative screening of phage-display peptide libraries with antibodies. In: Morris GE (ed.): "Epitope mapping protocols." Methods in Molecular Biology, vol.66, Totowa, NJ: Humana Press, pp 195-206.
17. Prezzi C, Nuzzo M, Meola A, Delmastro P, Galfre G, Cortese R, Nicosia A, Monaci P (1996): Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. The Journal of Immunology 156:4504-4513.
18. Pujol FH, Khudyakov YE, Devesa M, Leon G, Blitz-Dorfman L, Monsalve F, Lambert SB, Kalinina TY, Liprandi F, Fields HA (1996): Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome. Viral Immunology 9:89-96.
19. Sallberg M., Pumpen P., Zhang Z-X., Lundholm P, Gusars I, Ruden U, Wahren B Magnius LO (1994): Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein. Journal of Medical Virology 43:62-68.
20. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, Follett EC, Yap PL, Marsden H (1993): Mapping of serotypespecific, immunodominant epitopes in the NS4-region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infections with HCV types 1,2,and 3. Journal of Clinical Microbiology 31:1493-1503.
21. Smith GP (1992): "Cloning in f USE vectors." Available directly from Prof. G.P. Smith, Division of Biological Sciences, University of Missouri.
22. Van Doom LJ (1994): Review: Molecular biology of the hepatitis C virus. Journal of Medical Virology 43:345-356.
23. Wang LF, Meng Yu (1996): Random fragment libraries displayed on filamentous phage. In: Morris GE (ed.): "Epitope Mapping Protocols," Methods in Molecular Biology, vol.66, Totowa, NJ: Humana Press, pp 269-288.
24. Zhang ZX, Chen M, Sonnerborg A, Sallberg M (1994): Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): Anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection. Clinical and Diagnostic Laboratory Immunology 1:290-294.